Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Pancreatic Neoplasms 17Carcinoma, Non-Small-Cell Lung 9Triple Negative Breast Neoplasms 8Lung Neoplasms 7Breast Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Neoplasm Metastasis 4Biliary Tract Neoplasms 4Recurrence 3Parkinson Disease 4, Autosomal Dominant Lewy Body 3Esophageal Squamous Cell Carcinoma 3Cholangiocarcinoma 3Stomach Neoplasms 2Pancreatic Adenocarcinoma 2Ovarian Neoplasms 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Advanced Solid Tumor 2Uterine Cervical Neoplasms 1Squamous Cell Non-small Cell Lung Cancer 1Salivary Gland Neoplasms 1Rectal Neoplasms 1Neoplasms, Basal Cell 1Muscle-Invasive Bladder Carcinoma 1Metastatic Pancreatic Ductal Adenocarcinoma 1Metastatic Pancreatic Adenocarcinoma 1Melanoma, Cutaneous Malignant 1Lymphoma 1Locally Advanced or Metastatic Solid Tumors 1Locally Advanced Pancreatic Cancer 1

Interventions

sintilimab 1Radiation 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Locally Advanced Cervical Carcinoma × Albumin-Bound Paclitaxel × Clear all
NCT06391190 2024-04-30

Concurrent Chemoradiotherapy Followed by PD-1 Inhibitor in Advanced Cervical Cancer

RenJi Hospital

Phase 1/2 Recruiting
20 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡